ReviewNature reviews. Endocrinology2025
Body weight regulation models in humans: insights for testing their validity.
Review in Nature reviews. Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Behavioral Domains and Physiological Characteristics in Young Adults: Findings from Integrated Seven-Day Self-Monitoring and Physiological Assessment.Life (Basel, Switzerland) · 2026Article
- Lipid Metabolic Disorders: a Pivotal Driver in Type 2 Diabetes Mellitus Pathogenesis.Current obesity reports · 2026Review
- Intermittent oral administration of iron oxide nanoparticles modulates iron homeostasis, hematological, inflammatory, and organ-specific responses in iron-deficient rats.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Adipose cellularity and long-term development of impaired glucose metabolism: Swedish cohort study from 1988 through 2016.EBioMedicine · 2026Article
- A Combination of Plant-Derived Extracts Modulates Nutrient-Responsive Metabolic Signalling in an In Vitro Gut-Liver-Adipose Model.Nutrients · 2026Article
- Obesity: a disease of the ponderostat and the regulation of energy balance.Eating and weight disorders : EWD · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining a 'healthy' body weight is crucial for survival and involves a partially understood regulatory system that adjusts energy intake and energy output (expenditure and losses) for that purpose. Several models of body weight regulation exist, but experiments testing their validity are lacking. This Review elaborates on how to test the validity of body weight regulation models in humans. We begin by highlighting the interaction between the obesogenic environment and the individual's biological sensitivity to such environment, which triggers obesity in many, but not all, individuals. We discuss the identity of the regulated parameter(s), often considered to be body weight or body adiposity. We then focus on two models: set point and dual-intervention point. Under the set point model, obesity results from a malfunction of the system (leptin resistance) for preventing weight increases above the defended value. Under the dual-intervention point model, obesity occurs because the system tolerates a wide range of weights in some individuals. This key difference predicts different compensatory responses to energy balance perturbations in individuals according to their weight status, thus becoming instrumental in testing the validity of the models. Finally, we discuss the design of proof-of-concept experiments to advance the understanding of body weight regulation in humans.
Indexed as
Identifiers
40707700What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.